Procalcitonin: "To Follow or Not to Follow" That's the Question

Affiliations

Editorial

Subhash K Todi. Indian J Crit Care Med. 2021 May.

. 2021 May;25(5):484-485.

doi: 10.5005/jp-journals-10071-23840.

¹ Department of Critical Care Medicine, AMRI Hospitals, Kolkata, West Bengal, India.

Abstract

How to cite this article: Todi SK. Procalcitonin: "To Follow or Not to Follow" That's the Question. Indian J Crit Care Med 2021;25(5):484-485.

Source of support: Nil Conflict of interest: None

1. Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: Analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200–211. doi: 10.1016/S0140-6736(19)32989-7. - DOI - PMC - PubMed
1. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–1596. doi: 10.1097/01.CCM.0000217961.75225.E9. - DOI - PubMed
1. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115(2):462–474. doi: 10.1378/chest.115.2.462. - DOI - PubMed
1. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–377. doi: 10.1007/s00134-017-4683-6. - DOI - PubMed
1. Sawyer RG, Claridge JA, Nathens AB, Rotstein OD, Duane TM, Evans HL, et al. Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med. 2015;372(21):1996–2005. doi: 10.1056/NEJMoa1411162. - DOI - PMC - PubMed